Nicholas Vogelzang, MD, Comprehensive Cancer Center
Advertisement
Articles by Nicholas Vogelzang, MD, Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Repeat Molecular Testing in Advanced Prostate CancerPublished: March 18th 2020 | Updated:
mCRPC: Advice for Treatment During COVID-19Published: March 18th 2020 | Updated:
CARD Trial In Metastatic CRPCPublished: March 18th 2020 | Updated:
Sequencing Therapy in Castrate-Resistant Prostate CancerPublished: March 18th 2020 | Updated:
Counseling Patients With mCRPCPublished: March 18th 2020 | Updated:
Using Taxanes Frontline in Metastatic Prostate CancerPublished: March 18th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5